ES278660A1 - Procedimiento para la obtención de n-(ternario-aminoalquil) banzamidas sustituídas - Google Patents

Procedimiento para la obtención de n-(ternario-aminoalquil) banzamidas sustituídas

Info

Publication number
ES278660A1
ES278660A1 ES278660A ES278660A ES278660A1 ES 278660 A1 ES278660 A1 ES 278660A1 ES 278660 A ES278660 A ES 278660A ES 278660 A ES278660 A ES 278660A ES 278660 A1 ES278660 A1 ES 278660A1
Authority
ES
Spain
Prior art keywords
ternario
banzamidas
aminoalquil
substitute
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES278660A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Original Assignee
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dEtudes Scientifiques et Industrielles de lIle de France SA filed Critical Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Publication of ES278660A1 publication Critical patent/ES278660A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES278660A 1961-07-25 1962-06-19 Procedimiento para la obtención de n-(ternario-aminoalquil) banzamidas sustituídas Expired ES278660A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR869010A FR1313758A (fr) 1961-07-25 1961-07-25 Nouveaux benzamides substitués et leur procédé de préparation

Publications (1)

Publication Number Publication Date
ES278660A1 true ES278660A1 (es) 1962-10-16

Family

ID=8760052

Family Applications (1)

Application Number Title Priority Date Filing Date
ES278660A Expired ES278660A1 (es) 1961-07-25 1962-06-19 Procedimiento para la obtención de n-(ternario-aminoalquil) banzamidas sustituídas

Country Status (11)

Country Link
US (2) US3177252A (es)
JP (2) JPS5145651B1 (es)
BR (1) BR6240890D0 (es)
CH (1) CH425763A (es)
DK (1) DK106557C (es)
ES (1) ES278660A1 (es)
FI (1) FI42075B (es)
FR (1) FR1313758A (es)
NL (1) NL281394A (es)
OA (1) OA01153A (es)
SE (2) SE313555B (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281394A (es) * 1961-07-25
GB1019781A (es) * 1963-03-05
FR1407055A (fr) * 1963-03-05 1965-07-30 Ile De France Nouveau procédé de préparation de benzamides substitués
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
US3885033A (en) * 1967-04-03 1975-05-20 Ile De France Method of anesthetizing a mammal by administration of a substituted 2-arylalkyloxy benzamide
US3509166A (en) * 1968-01-15 1970-04-28 American Cyanamid Co Tetrahydro-pyridine derivatives of benzamide
JPS4940459B1 (es) * 1970-12-21 1974-11-02
GB1399632A (en) * 1972-07-13 1975-07-02 Leo Pharm Prod Ltd Sulphamoyl-benzoic acids
CA1082181A (en) * 1976-06-03 1980-07-22 Eric A. Watts Benzamide derivatives
US4255580A (en) * 1976-08-04 1981-03-10 Siociete D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene bis (oxy) benzamides and derivatives
US4140769A (en) 1976-12-23 1979-02-20 Miles Laboratories, Inc. 3-Substituted salicylamides
US4109005A (en) * 1977-05-11 1978-08-22 A. H. Robins Company, Inc. Method of increasing rate of gastric emptying with pyrrolidinylbenzamides
JPS54130599A (en) * 1978-03-31 1979-10-09 Taisho Pharmaceut Co Ltd Furoindole derivative
JPS54148743A (en) * 1978-05-12 1979-11-21 Asahi Chem Ind Co Ltd Production of methoclopramide
JPS6058224B2 (ja) * 1978-07-31 1985-12-19 旭化成株式会社 メトクロプラミドの製造方法
FR2446274A1 (fr) * 1979-01-15 1980-08-08 Delalande Sa Nouveaux derives de salicylamide, leur procede de preparation et leur application en therapeutique
US4301159A (en) * 1980-06-20 1981-11-17 Shionogi & Co., Ltd. N-(Diethylaminoethyl)-2-alkoxy-benzamide derivatives
US4440941A (en) * 1980-12-22 1984-04-03 Usv Pharmaceutical Corporation Aroyl-aminoacids, amides and esters thereof
US4536386B1 (en) * 1981-01-26 1995-03-07 Robins Co Inc A H Method of controlling emesis caused by cisplatin in cancer chemotherapy
US4666911A (en) * 1981-07-14 1987-05-19 Taiho Pharmaceutical Company Limited Allophanoylpiperazine compound and analgesic composition containing same as active ingredient
JPS59186969A (ja) * 1983-04-08 1984-10-23 Yoshitomi Pharmaceut Ind Ltd ベンゾフラン−およびベンゾピランカルボキサミド誘導体
US4501749A (en) * 1983-10-31 1985-02-26 Merck & Co., Inc. Peripherally selective dopamine antagonists in the treatment of ocular hypertension
FR2557110B1 (fr) * 1983-12-23 1989-11-24 Sandoz Sa Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
US5011992A (en) * 1984-06-28 1991-04-30 Bristol-Myers Squibb Company Pharmacologically active substituted benzamides
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides
US4772630A (en) * 1984-11-23 1988-09-20 Ciba-Geigy Corp. Benzamides and their salts
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
GB8708833D0 (en) * 1987-04-13 1987-05-20 Lilly S A E Organic compounds
IT1216120B (it) * 1988-03-17 1990-02-22 Poli Ind Chimica Spa Derivati n_cicloalchilaminoetilbenzamidici, loro preparazione e composizioni farmaceutiche che li contengono.
GB8823041D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
GB8823040D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
GB8823042D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
IT1266992B1 (it) * 1993-04-16 1997-01-24 Alfa Wassermann Spa Composti eterociclici, a struttura correlabile alle banzammidi, attivi nelle patologie gastro-intestinali, ad attivita' procinetica ed
US20040192781A1 (en) * 2003-03-31 2004-09-30 Haley Eugene T. Method of administration for metoclopramide and pharmaceutical formulation therefor
US20050137265A1 (en) * 2003-03-31 2005-06-23 Haley Eugene T. Rapidly dissolving metoclopramide solid oral dosage and method thereof
JP5064216B2 (ja) 2004-07-16 2012-10-31 プロテオシス・アーゲー 炎症性疾患用治療剤としての、parp及びsir調節活性を有するムスカリンアンタゴニスト
JP2010510227A (ja) 2006-11-20 2010-04-02 プレジデント アンド フェロウズ オブ ハーバード カレッジ 痛みおよび痒みの治療方法、組成物およびキット
WO2010081825A2 (en) 2009-01-13 2010-07-22 Proteosys Ag Pirenzepine as an agent in cancer treatment
EP3485881B1 (en) 2009-07-10 2024-03-13 President and Fellows of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
PT2747561T (pt) 2011-08-25 2018-09-28 Evoke Pharma Inc Tratamento de sintomas associados com a gastroparesia feminina
EP2895457B1 (en) 2012-09-17 2020-05-20 Nektar Therapeutics Oligomer-containing benzamide-based compounds
MX2018001447A (es) 2015-08-03 2019-02-21 Harvard College Bloqueadores de canal de ion cargado y metodos para su uso.
AU2019322187A1 (en) 2018-08-15 2021-03-25 Pharmacyl Ab Substituted benzamides and their use in therapy
WO2020035554A1 (en) 2018-08-15 2020-02-20 Pharmacyl Ab A new medical treatment for pathologic inflammation
JP2022527438A (ja) 2019-03-11 2022-06-02 ノシオン セラピューティクス,インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2020185881A1 (en) 2019-03-11 2020-09-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2021091586A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP2023500891A (ja) 2019-11-06 2023-01-11 ノシオン セラピューティクス,インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
US11717500B2 (en) 2020-02-03 2023-08-08 Pharmacyl Ab Treatment of spondyloarthritis
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE620543A (es) *
US2460139A (en) * 1945-07-21 1949-01-25 Wallace & Tiernan Inc Alkamine esters of 2-chloro-4-amino benzoic acid
US2691025A (en) * 1951-03-30 1954-10-05 Sterling Drug Inc N-(tertiary-aminoalkyl)-2, 4-disubstituted-benzamides and their preparation
US2810718A (en) * 1953-07-02 1957-10-22 Abbott Lab Basic salicylamides
GB797476A (en) * 1955-09-09 1958-07-02 Bristol Lab Inc Amides of trialkoxybenzoic acids
US2910488A (en) * 1958-01-22 1959-10-27 Merck & Co Inc Aniline derivatives
NL281394A (es) * 1961-07-25

Also Published As

Publication number Publication date
BR6240890D0 (pt) 1973-06-14
OA01153A (fr) 1968-08-07
FR1313758A (fr) 1963-01-04
CH425763A (fr) 1966-12-15
US3312739A (en) 1967-04-04
US3177252A (en) 1965-04-06
JPS5145651B1 (es) 1976-12-04
FI42075B (es) 1970-02-02
SE313555B (es) 1969-08-18
DK106557C (da) 1967-02-20
NL281394A (es)
JPS5216104B1 (es) 1977-05-06
SE372009B (es) 1974-12-09

Similar Documents

Publication Publication Date Title
ES278660A1 (es) Procedimiento para la obtención de n-(ternario-aminoalquil) banzamidas sustituídas
DK132797C (da) Fremgangsmade til fremstilling af alfa-aminobenzylpenicilliner
ES288574A1 (es) Procedimiento para la obtención de nuevos tetrahidro-imidazoles
ES255292A3 (es) Procedimiento para la fabricaciën de cables dipolares
ES269680A3 (es) Procedimiento de fabricaciën de un material elastico
ES254954A2 (es) Procedimiento para la preparaciën de carnitina
ES546462A0 (es) Metodo para la preparacion de 3-oxo- 4-6-metilesteroides
ES546463A0 (es) Metodo para la preparacion de 6-metilen-3-oxo- 4-esteroides
ES88557Y (es) Instrumento para dibujar
ES86619Y (es) Dispositivo perfeccionado para la colocación graduable de entrepaños en estanterías desmontables
ES88704Y (es) Gancho-soporte universal para estructuras desmontables
ES92058Y (es) Pieza para la creación de estructuras desmontables
ES244600A1 (es) Procedimiento para la reducciën de compuestos borohidrogenicos
ES277540A1 (es) Procedimiento y aparato para la obtención de estireno
ES259588A1 (es) Procedimiento y dispositivo para la fabricaciën de azufre en polvo
ES84772Y (es) Dispositivo mejorado para fijación
ES89896Y (es) Pandereta perfeccionada
ES300037A1 (es) Procedimiento para la preparación de éteres beta-cianoetil-halogen-alquílicos
ES298238A1 (es) Procedimiento para la obtención de compuestos acilamínicos
ES253885A1 (es) Procedimiento para la obtenciën de amidas ciclicas
ES252063A1 (es) Procedimiento simplificado para la confecciën de camiusas para caballero
ES90681Y (es) Unión para correas trapezoidales
ES85686Y (es) Alpargata ortopédica
ES89827Y (es) Bloque para la formación de calzados
ES86825Y (es) Caballe-andamio para la construcción